Gliadel
carmustine
Listed by Azurity Pharmaceuticals, Inc.
- Strength
- 7.7 mg/1
- Form
- Wafer
- Route
- Intracavitary
- Class
- Alkylating Drug
What it contains
- Carmustine 7.7 mg/1
FDA record
| Dosage form | Wafer |
|---|---|
| Route | Intracavitary |
| Drug class | Alkylating Drug |
| Approval route | NDA — original brand approval |
| NDC code | 24338-050 |
| FDA application | NDA020637 |
| RxNorm concept | 212994 |
| Package sizes listed | 1 |
| Marketed since | December 2012 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.